Attention Bias Modification Treatment for Adolescents With Major Depression: A Randomized Controlled Trial - 22/02/16
, John X. Zhang, PhD b, Zhirui Ding, MS a, Lihui Xiao, MS aAbstract |
Objective |
Attention bias modification (ABM) is a promising treatment for depression, but trial data remain restricted to adults. The present trial examined effects of ABM on adolescent depression.
Method |
A total of 45 adolescents with major depressive disorder (MDD), selected from a school population (n = 2,731) using a 2-stage case-finding procedure, were randomized to an active ABM intervention (n = 23) or placebo ABM training (n = 22). In the active condition, participants completed a neutral ABM over 2 weeks for 8 sessions (320 trials each) to shift attention away from sad words to neutral words. At a 9-week follow-up, they received a positive ABM for 2 weeks with 4 more sessions (480 trials each), shifting attention to positive words. The placebo training used the same tasks but shifted attention toward neutral and sad words equally often. Attentional biases and clinical status determined by semi-structured interviews and questionnaires were obtained before and after each training. Depressive symptoms were reassessed at 8- and 12-month follow-ups.
Results |
Greater reductions in attentional bias score and clinician-rated depressive symptoms were found for active ABM compared with placebo after initial neutral ABM. More participants no longer met diagnostic criteria for MDD in active ABM than in placebo. Greater reductions in self-reported depressive and anxious symptoms at the 12-month follow-up were also found in active ABM compared with placebo.
Conclusion |
ABM may be a potential treatment tool for mild to moderate adolescent major depression.
Clinical trial registration information—Attention Bias Modification Treatment for Major Depressive Disorder in Adolescents: A Randomized Controlled Trial; clinicaltrials.gov/; NCT02078258.
Le texte complet de cet article est disponible en PDF.Key words : major depression, attention bias modification (ABM), treatment, adolescent
Plan
| This article is discussed in an editorial by Drs. Amit Lazarov and Yair Bar-Haim on page 161. |
|
| Clinical guidance is available at the end of this article. |
|
| This work is supported by the National Social Science Foundation for the 12th Five-Year Planning of Education of China (grant no. BBA130016 to Dr. Yang). |
|
| Mr. Ding served as the statistical expert for this research. |
|
| The authors thank Fang Peng, MA, Ting Zhou, MS, Shaoliang Liu, BS, Ximei Liu, MA, Li Li, MS, and Chaoming Yang, MS, of Hunan Normal University, for assistance in data collection, Randy P. Auerbach, PhD, and Jeremy G. Stewart, PhD, of Harvard Medical School, for comments on the manuscript, and Teddy Wing, BS, of Riveren Software, for editing the revised manuscript. |
|
| Disclosure: Drs. Yang and Zhang, Mr. Ding, and Ms. Xiao report no biomedical financial interests or potential conflicts of interest. |
Vol 55 - N° 3
P. 208 - mars 2016 Retour au numéro
Article précédent
- A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation
- James G. Waxmonsky, Daniel A. Waschbusch, Peter Belin, Tan Li, Lysett Babocsai, Hugh Humphery, Meaghan E. Pariseau, Dara E. Babinski, Martin T. Hoffman, Jenifer L. Haak, Jessica R. Mazzant, Gregory A. Fabiano, Jeremy W. Pettit, Negar Fallahazad, William E. Pelham
- Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects
- V. Robin Weersing, Wael Shamseddeen, Judy Garber, Steven D. Hollon, Gregory N. Clarke, William R. Beardslee, Tracy R. Gladstone, Frances L. Lynch, Giovanna Porta, Satish Iyengar, David A. Brent
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?